SCHEMBL4768261

SCHEMBL4768261

CS(=O)(=O)N(Cc1ccccc1C(F)(F)F)c1ccc(N(C=O)Cc2ccc(C(F)(F)F)nc2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 1/20 0.38
SLC6A2 P23975 1/20 0.37
SLC6A4 P31645 1/20 0.37
SLC6A3 Q01959 1/20 0.37
CYP2C9 P11712 1/20 0.35
SLC22A6 Q4U2R8 1/20 0.35
SLC22A8 Q8TCC7 1/20 0.35
SLC22A12 Q96S37 1/20 0.35
SLC22A11 Q9NSA0 1/20 0.35
HDAC6 Q9UBN7 2/20 0.35
GRM2 Q14416 2/20 0.34
PTK2 Q05397 2/20 0.34
NR3C1 P04150 1/20 0.34
KCNH2 Q12809 1/20 0.34
RORC P51449 2/20 0.33
GAA P10253 1/20 0.33
RECQL P46063 1/20 0.33
HDAC11 Q96DB2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
AGTR1 P30556 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4771247 0.90 ALDH1A1 (0.42) TRPM8HDAC6GRM2RECQLALDH1A1
SCHEMBL5571164 0.90 GAA (0.44) TRPM8HDAC6GRM2KCNH2GAA
SCHEMBL4772997 0.88 TRPM8 (0.39) TRPM8HDAC6ALDH1A1
SCHEMBL4773365 0.88 LMNA (0.36) HDAC6GRM2PTK2GAARECQL
SCHEMBL4768211 0.87 TRPM8 (0.36) TRPM8CYP2C9HDAC6GRM2NR3C1
SCHEMBL4776872 0.87 RECQL (0.39) HDAC6GRM2KCNH2RECQLALDH1A1
SCHEMBL4776637 0.86 RECQL (0.36) TRPM8HDAC6RECQLALDH1A1AGTR1
SCHEMBL4772347 0.86 GAA (0.37) TRPM8HDAC6KCNH2GAARECQL
SCHEMBL4772420 0.85 GAA (0.37) TRPM8HDAC6GAARECQL
SCHEMBL4770843 0.85 LMNA (0.36) HDAC6KCNH2RORCGAARECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1942888-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS Cytokinetics, Inc. (US) 2008-07-16 EP claimed
US-20070135435-A1 Certain chemical entities, compositions, and methods CYTOKINETICS, INCORPORATED 2007-06-14 US claimed
WO-2007056078-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS CYTOKINETICS, INC. (US) 2007-05-18 WO claimed
US-20070135435-A1 Certain chemical entities, compositions, and methods CYTOKINETICS, INCORPORATED 2007-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135435-A1 Certain chemical entities, compositions, and methods KIF5B, KIF2C, PLK1 TRPM8 3499/4885SLC6A2 3818/4885SLC6A4 3990/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.